StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
225
This month
3
This year
39
Publishing Date
2024 - 03 - 27
3
2024 - 03 - 11
3
2024 - 03 - 08
2
2024 - 02 - 16
3
2024 - 02 - 15
2
2024 - 01 - 25
3
2024 - 01 - 17
2
2024 - 01 - 15
2
2023 - 12 - 22
2
2023 - 11 - 27
2
2023 - 10 - 23
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 11
2
2023 - 08 - 18
2
2023 - 07 - 17
2
2023 - 07 - 03
2
2023 - 05 - 10
2
2023 - 05 - 03
2
2023 - 03 - 21
2
2023 - 02 - 24
2
2023 - 01 - 30
2
2023 - 01 - 27
2
2022 - 12 - 16
2
2022 - 12 - 15
2
2022 - 11 - 17
3
2022 - 11 - 09
2
2022 - 11 - 04
3
2022 - 10 - 10
3
2022 - 09 - 28
2
2022 - 06 - 28
3
2022 - 06 - 07
2
2022 - 05 - 20
2
2022 - 04 - 07
2
2022 - 03 - 28
2
2022 - 03 - 15
2
2022 - 02 - 24
2
2022 - 01 - 31
2
2021 - 10 - 20
2
2021 - 08 - 06
2
2021 - 07 - 29
2
2021 - 06 - 25
4
2021 - 06 - 11
2
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 04 - 30
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 04 - 01
1
2021 - 03 - 31
2
2021 - 03 - 26
1
2021 - 03 - 24
1
2021 - 03 - 19
3
2021 - 02 - 23
2
2020 - 12 - 18
1
Sector
Consumer non-durables
1
Finance
2
Health technology
225
Manufacturing
3
N/a
2
Process industries
1
Technology services
1
Tags
Alliances
6
Als
2
Anemia
4
Antibody
5
Approval
97
Approved
41
Astrazeneca
3
Beyfortus
3
Biocanada
3
Biotechnology
8
Canada
3
Cancer
35
Car-t
3
Cell
3
Children
20
China
5
Chmp
8
Copd
5
Covid
6
Covid-19
5
Dermatitis
7
Diabetes
3
Disease
18
Drug
17
Dupixent
37
Europe
9
Fda
97
Fda approval
16
Fda-approvals
45
First
9
Growth
6
Hypertension
3
Immunotherapy
4
Injection
6
Japan
4
Keytruda
3
Libtayo
7
Lung
4
Lung cancer
3
Market
10
Multiple sclerosis
3
N/a
106
News
8
Order
4
Pharm-country
5
Pharmaceutical
9
Positive
7
Potential
8
Rare
3
Regulatory
19
Report
5
Research
8
Rsv
4
Sanofi
11
Sclerosis
3
Six
4
Submission
3
Therapy
12
Treatment
56
Vaccine
13
Entities
Abbott laboratories
38
Abbvie inc.
13
Acadia pharmaceuticals inc.
1
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Albemarle corporation
1
Alnylam pharmaceuticals, inc.
12
Amgen inc.
11
Arrival
1
Astrazeneca plc
4
Aveo pharmaceuticals, inc.
18
Avista public acquisition corp. ii
2
Baidu, inc.
1
Beigene, ltd.
10
Biogen inc.
1
Biontech se
5
Blueprint medicines corporation
18
Bristol-myers squibb company
19
Byline bancorp, inc.
1
Clovis oncology, inc.
18
Dynavax technologies corporation
1
Eli lilly and company
27
Epizyme, inc.
18
Exelixis, inc.
10
Glaxosmithkline plc
5
Illumina, inc.
10
Incyte corporation
23
Johnson & johnson
57
Karyopharm therapeutics inc.
18
Ligand pharmaceuticals incorporated
5
Mobiv acquisition corp
2
Morgan stanley
1
Neurocrine biosciences, inc.
1
Neuropace inc
1
Novartis ag
3
Novo nordisk a/s
1
Perrigo company
54
Pfizer, inc.
16
Provention bio, inc.
4
Puma biotechnology inc
1
Rcf acquisition corp.
2
Reckitt benckiser group plc
1
Regeneron pharmaceuticals, inc.
63
Rigel pharmaceuticals, inc.
10
Sanofi
225
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
16
Thermo fisher scientific inc
1
Verastem, inc.
10
Viatris inc.
2
Y-mabs therapeutics, inc.
18
Zealand pharma a/s
1
Symbols
ABBV
58
ABT
61
ADCT
20
ADMA
18
AGIO
12
ALNY
13
AMGN
31
AMRX
17
ANIP
19
ARVL
24
AVEO
22
AZN
19
BCRX
16
BGNE
34
BIIB
26
BMY
60
BPMC
24
CALT
12
CLVS
20
CNSP
13
EPZM
19
EXEL
14
FNCTF
49
FRG
16
FST
13
GH
12
GILD
27
GSK
15
ILMN
13
IMMX
12
INCY
52
JAGX
16
JNJ
192
KMDA
15
KPTI
32
LLY
79
LTUM
15
MDT
35
MRK
51
MRNA
13
MS
21
NBR
19
NVAX
15
NVO
13
NVS
39
NVSEF
31
PAC
12
PFE
57
PRGO
62
REGN
69
RIGL
12
SNY
225
SNYNF
176
TAK
34
TEVJF
27
TMO
15
VRTX
12
VSAC
16
WGO
13
YMAB
21
Exchanges
Nasdaq
225
Nyse
96
Crawled Date
2024 - 03 - 27
3
2024 - 03 - 11
3
2024 - 03 - 08
2
2024 - 02 - 16
3
2024 - 02 - 15
2
2024 - 01 - 25
3
2024 - 01 - 17
2
2024 - 01 - 15
2
2023 - 12 - 22
2
2023 - 11 - 27
2
2023 - 10 - 23
2
2023 - 10 - 05
2
2023 - 10 - 02
2
2023 - 09 - 11
2
2023 - 08 - 18
2
2023 - 07 - 17
2
2023 - 07 - 03
2
2023 - 05 - 10
2
2023 - 05 - 03
2
2023 - 04 - 28
2
2023 - 03 - 21
2
2023 - 02 - 24
2
2023 - 01 - 30
2
2023 - 01 - 27
2
2022 - 12 - 16
2
2022 - 12 - 15
2
2022 - 11 - 17
3
2022 - 11 - 09
2
2022 - 11 - 04
3
2022 - 10 - 10
3
2022 - 09 - 28
2
2022 - 06 - 28
3
2022 - 06 - 07
2
2022 - 05 - 20
2
2022 - 04 - 07
2
2022 - 03 - 28
2
2022 - 03 - 15
2
2022 - 02 - 24
2
2022 - 01 - 31
2
2021 - 10 - 20
2
2021 - 08 - 06
2
2021 - 07 - 29
2
2021 - 06 - 25
4
2021 - 06 - 11
2
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 04 - 30
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
2021 - 04 - 01
1
2021 - 03 - 31
2
2021 - 03 - 26
1
2021 - 03 - 24
1
2021 - 03 - 19
3
2021 - 02 - 23
2
2020 - 12 - 18
1
Crawled Time
00:00
6
00:01
1
01:00
3
02:00
1
04:00
2
05:00
1
06:00
12
07:00
9
08:00
7
10:00
1
11:00
5
11:36
1
11:49
1
12:00
5
12:20
3
12:30
3
12:53
1
13:00
9
13:13
1
13:15
1
13:20
1
13:30
8
13:50
1
14:00
14
14:20
3
14:30
9
14:58
1
15:00
12
15:20
2
15:30
6
16:00
10
17:00
18
17:37
1
18:00
12
18:04
1
18:17
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
5
19:11
1
19:32
1
19:52
1
20:00
6
20:59
1
21:00
9
22:00
11
23:00
11
Source
spacfeed.com
3
www.biospace.com
119
www.fda.gov
20
www.globenewswire.com
43
www.prnewswire.com
40
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
symbols :
Sny
save search
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published:
2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.62%
|
O:
2.24%
H:
0.0%
C:
-0.8%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.59%
|
O:
0.96%
H:
1.17%
C:
0.16%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-5.3%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-1.79%
|
O:
0.09%
H:
0.16%
C:
-0.7%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.25%
|
O:
0.84%
H:
0.0%
C:
0.0%
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.34%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.42%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-2.51%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.84%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published:
2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-6.7%
|
O:
-1.09%
H:
0.13%
C:
-1.39%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.45%
|
O:
-0.77%
H:
0.8%
C:
0.74%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-2.57%
|
O:
-0.18%
H:
0.47%
C:
0.12%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.94%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
approval
astrazeneca
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published:
2024-03-29
(Crawled : 19:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
fda
hepatitis
kidney
anemia
FDA Approves New Treatments for Two Rare Diseases
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-7.85%
|
O:
-0.26%
H:
0.0%
C:
0.0%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-2.73%
|
O:
0.84%
H:
1.48%
C:
1.29%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.18%
|
O:
0.3%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-1.11%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-6.77%
|
O:
1.06%
H:
0.0%
C:
0.0%
fda
rare
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: Glo...
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-7.85%
|
O:
-0.26%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-6.77%
|
O:
1.06%
H:
0.0%
C:
0.0%
copd
potential
market
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published:
2024-03-27
(Crawled : 12:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-7.85%
|
O:
-0.26%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-6.77%
|
O:
1.06%
H:
0.0%
C:
0.0%
copd
potential
market
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published:
2024-03-25
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.71%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.34%
|
O:
0.35%
H:
0.35%
C:
-1.34%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.14%
|
O:
0.04%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-1.23%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.58%
|
O:
0.42%
H:
0.0%
C:
0.0%
approved
treatment
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published:
2024-03-22
(Crawled : 14:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-3.26%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-5.13%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.13%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-2.49%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.35%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published:
2024-03-21
(Crawled : 13:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.9%
|
O:
0.14%
H:
0.24%
C:
0.24%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.28%
|
O:
0.0%
H:
1.6%
C:
0.89%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.15%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-3.04%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.06%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
drug
iclusig
hypertension
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published:
2024-03-18
(Crawled : 23:00)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-1.35%
|
O:
0.33%
H:
0.13%
C:
-1.51%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.72%
|
O:
0.2%
H:
0.08%
C:
-1.14%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-3.7%
|
O:
1.71%
H:
0.36%
C:
-2.52%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.27%
|
O:
-0.81%
H:
0.0%
C:
0.0%
fda
rare
first
disease
therapy
Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published:
2024-03-15
(Crawled : 15:00)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-2.95%
|
O:
-0.62%
H:
0.59%
C:
-1.01%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.16%
|
O:
-1.58%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.03%
|
O:
-5.53%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.29%
|
O:
-0.02%
H:
0.0%
C:
0.0%
fda
breyanzi
week
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-0.96%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.11%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.59%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.56%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published:
2024-03-11
(Crawled : 14:30)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-0.96%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.11%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.59%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.56%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol
Published:
2024-03-11
(Crawled : 11:00)
- globenewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.56%
|
O:
0.57%
H:
0.0%
C:
0.0%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
-7.71%
|
O:
0.23%
H:
0.9%
C:
-0.68%
praluent
fda
children
genetic
cholesterol
approval
treat
injection
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published:
2024-03-08
(Crawled : 18:00)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
0.91%
|
O:
0.98%
H:
3.17%
C:
0.9%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.74%
|
O:
-0.68%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.06%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.64%
|
O:
-0.08%
H:
0.0%
C:
0.0%
fda
brukinsa
approval
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published:
2024-03-08
(Crawled : 17:00)
- biospace.com/
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
0.91%
|
O:
0.98%
H:
3.17%
C:
0.9%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.74%
|
O:
-0.68%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.06%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.64%
|
O:
-0.08%
H:
0.0%
C:
0.0%
fda
opdivo
approved
approval
Decision Tracker: FDA Decisions: Amgen’s Bone-Preserving Blockbuster Picks Up Two New Challengers
Published:
2024-03-06
(Crawled : 14:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.64%
|
O:
0.0%
H:
0.8%
C:
0.8%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
9.9%
|
O:
-0.15%
H:
3.43%
C:
3.2%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.08%
|
O:
-0.67%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.3%
|
O:
-1.65%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.53%
|
O:
-0.45%
H:
0.0%
C:
0.0%
fda
FDA Decisions: J&J’s Rybrevant Becomes First Front-Line Treatment for Type of NSCLC
Published:
2024-03-04
(Crawled : 14:30)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.52%
|
O:
-0.9%
H:
0.0%
C:
0.0%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
13.79%
|
O:
0.65%
H:
1.13%
C:
-1.02%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.74%
|
O:
-0.42%
H:
0.0%
C:
0.0%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-7.82%
|
O:
0.03%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.19%
|
O:
-0.8%
H:
0.0%
C:
0.0%
fda
first
treatment
rybrevant
FDA Decisions: Multiple Issues Cited in Rejection of Minerva’s Schizophrenia ...
Published:
2024-02-29
(Crawled : 15:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-4.49%
|
O:
-1.6%
H:
0.0%
C:
0.0%
PRGO
4
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
13.44%
|
O:
0.11%
H:
0.98%
C:
-0.68%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.33%
|
O:
0.56%
H:
0.12%
C:
-0.38%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-9.03%
|
O:
0.22%
H:
0.1%
C:
-1.4%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.53%
|
O:
-0.11%
H:
0.0%
C:
0.0%
fda
schizophrenia
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.